Related Experiment Video
Updated: Nov 11, 2025

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
An Atypical Presentation of Serotonin Syndrome
Eric Landa1, Stephen Wagner1, Abilash Makkar1
1Internal Medicine, Unity Health, Searcy, USA.
This paper discusses an uncommon presentation of serotonin syndrome, emphasizing early recognition of symptoms for timely treatment. Prompt identification and discontinuation of causative agents are crucial for preventing life-threatening outcomes.
Area of Science:
- Pharmacology
- Clinical Toxicology
Background:
- Serotonin syndrome is a potentially life-threatening condition caused by excessive serotonergic activity.
- Understanding the diverse clinical manifestations is essential for accurate diagnosis.
Observation:
- This report details an uncommon presentation of serotonin syndrome.
- Recognizing atypical symptoms alongside typical signs is key to uncovering the condition.
Findings:
- Early identification of serotonin syndrome is critical for effective management.
- Discontinuation of offending agents is the primary treatment strategy.
Implications:
- Educated physicians and careful prescribing practices can mitigate the risk of serotonin toxicity.
- Timely diagnosis and intervention can prevent severe morbidity and mortality associated with serotonin syndrome.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antipsychotic Drugs: Typical and Atypical Agents
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

